Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Heck reaction route for HIV drug intermediate IDX-899. High selectivity, mild conditions, scalable manufacturing solution for pharmaceutical intermediates.
Patent CN108658871B details a continuous flow method for 4, 6-dichloro-5-methoxypyrimidine, offering high purity and reduced costs for API manufacturing.
Patent CN107840828B reveals a high-yield one-step fluorination route for 2-chloro-5-trifluoromethylpyrazine, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN101948389A reveals a high-yield route for Flumioxazin intermediates. Discover cost-effective manufacturing and scalable supply chain solutions for this critical agrochemical building block.
Patent CN117430521B reveals a safer Lewis acid catalyzed route for Glupa-C. Achieves 99.96% purity and enhanced supply chain reliability for clinical diagnostic manufacturing.
Patent CN113754694B reveals a novel chiral bicyclic imidazole catalyst method for Remdesivir. Achieve high-purity API intermediates with reduced manufacturing costs.
Patent CN110804051B reveals a mild, high-yield route for 3-alpha-homotropylamine. Discover cost-effective manufacturing and supply chain advantages.
Patent CN116829536B reveals single-step catalytic conversion for methionine. Offers high yield and supply chain stability for animal nutrition and pharma.
Patent CN110105305A enables green synthesis of 1,2-benzothiazine derivatives using ionic liquids, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel hydrolysis route for 2-(trifluoromethyl)benzaldehyde offers high purity and industrial scalability for pharma intermediates.
Patent CN110143935B details a novel Ru-catalyzed route to 2,5-disubstituted furans under air. This method offers mild conditions and high regioselectivity for reliable pharmaceutical intermediate supply.
Patent CN115093339A reveals a high-yield, eco-friendly route for L-glufosinate intermediates, offering significant cost reduction and supply chain stability for herbicide manufacturers.
Patent CN102285915B details a high-yield synthesis of Aspernigerin. This report analyzes cost reduction and scalability for pharmaceutical intermediate manufacturing.
Novel melt crystallization patent CN119977839A enables high-purity 2,4-DCBN production with significant cost reduction and supply chain reliability for global buyers.
Patent CN107188874A reveals efficient Cu-catalyzed Michael addition. High ee, mild conditions for pharma intermediates.
Novel rhodium-catalyzed route for indaziflam intermediate offers high ee value and industrial scalability for agrochemical supply chains.
Patent CN110483316B reveals a safe, in-situ ketene route for high-purity L-carnitine. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN113214263B reveals a high-yield synthetic route for Remdesivir key intermediates, offering significant cost reduction and scalable manufacturing for global pharmaceutical supply chains.
Patent CN1121706A reveals a non-halide route for substituted aromatic amines, offering cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN1042530C reveals a novel phase-transfer catalyzed route for alkylsulfinylbenzamides enabling cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.